The effects of antidepressants on the hypothalamic-pituitary-adrenal axis

被引:81
作者
Mason, Brittany L. [1 ]
Pariante, Carmine M. [1 ]
机构
[1] Kings Coll London, Stress Psychiat & Immunol Lab, Inst Psychiat, London WC2R 2LS, England
基金
英国医学研究理事会;
关键词
D O I
10.1358/dnp.2006.19.10.1068007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis has been found in some psychiatric disorders, especially in older patients with severe depression. Altered feedback inhibition, as demonstrated by increased circulating cortisol and nonsuppresssion of cortisol following administration of dexamethasone, may be to blame. Two glucocorticoid receptors control the HPA axis, the mineralocorticoid receptor (MR) and the glucocorticoid receptor (GR). MR regulates normal HPA fluctuations and the GR regulates in times of stress. Long-term antidepressant treatment in humans has been shown to upregulate both GR and MR in the brain, whereas short-term treatment has been shown to downregulate GR and MR. After 6-9 weeks of treatment GR function returns to normal, and the MR stays upregulated. Chronic antidepressant treatment in rodents has been shown to reduce HPA activity, even in the absence of GR or MR upregulation. These effects of antidepressants on HPA regulation may be attributed in part to regulation of the multidrug resistance protein transporter, P-glycoprotein. Finding relationships between antidepressant action and HPA regulation leads to the conclusion that the disruption of the HPA may be more a contributing factor to depression than other biological abnormalities. (C) 2006 Prous Science. All rights reserved.
引用
收藏
页码:603 / 608
页数:6
相关论文
共 61 条
[1]   Selective effects on NGFI-A, MR, GR and NGFI-B hippocampal mRNA expression after chronic treatment with different subclasses of antidepressants in the rat [J].
Bjartmar, L ;
Johansson, IM ;
Marcusson, J ;
Ross, SB ;
Seckl, JR ;
Olsson, T .
PSYCHOPHARMACOLOGY, 2000, 151 (01) :7-12
[2]   THE ANTIDEPRESSANTS FLUOXETINE, IDAZOXAN AND PHENELZINE ALTER CORTICOTROPIN-RELEASING HORMONE AND TYROSINE-HYDROXYLASE MESSENGER-RNA LEVELS IN RAT-BRAIN - THERAPEUTIC IMPLICATIONS [J].
BRADY, LS ;
GOLD, PW ;
HERKENHAM, M ;
LYNN, AB ;
WHITFIELD, HJ .
BRAIN RESEARCH, 1992, 572 (1-2) :117-125
[3]   LONG-TERM ANTIDEPRESSANT ADMINISTRATION ALTERS CORTICOTROPIN-RELEASING HORMONE, TYROSINE-HYDROXYLASE, AND MINERALOCORTICOID RECEPTOR GENE-EXPRESSION IN RAT-BRAIN - THERAPEUTIC IMPLICATIONS [J].
BRADY, LS ;
WHITFIELD, HJ ;
FOX, RJ ;
GOLD, PW ;
HERKENHAM, M .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (03) :831-837
[4]  
Budziszewska Boguslawa, 1994, Polish Journal of Pharmacology, V46, P147
[5]   Preservation of hypothalamic-pituitary-adrenal axis fast-feedback responses in depression [J].
Cooney, JM ;
Dinan, TG .
ACTA PSYCHIATRICA SCANDINAVICA, 1996, 94 (06) :449-453
[6]   Antidepressants blunt the effects of inescapable stress on male mating behaviour and decrease corticotropin-releasing hormone mRNA expression in the hypothalamic paraventricular nucleus of the Syrian hamster (Mesocricetus auratus) [J].
Cordner, AP ;
Herwood, MB ;
Helmreich, DL ;
Parfitt, DB .
JOURNAL OF NEUROENDOCRINOLOGY, 2004, 16 (07) :628-636
[7]   Brain corticosteroid receptor balance in health and disease [J].
De Kloet, ER ;
Vreugdenhil, E ;
Oitzl, MS ;
Joëls, M .
ENDOCRINE REVIEWS, 1998, 19 (03) :269-301
[8]   THE NOVEL ANTIDEPRESSANT, TIANEPTINE, REDUCES STRESS-EVOKED STIMULATION OF THE HYPOTHALAMO-PITUITARY-ADRENAL AXIS [J].
DELBENDE, C ;
CONTESSE, V ;
MOCAER, E ;
KAMOUN, A ;
VAUDRY, H .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 202 (03) :391-396
[9]   Increased synaptic availability of norepinephrine following desipramine is not essential for increases in GR mRNA - Short communication [J].
Eiring, A ;
Sulser, F .
JOURNAL OF NEURAL TRANSMISSION, 1997, 104 (11-12) :1255-1258
[10]   Contrasting effects of citalopram and reboxetine on waking salivary cortisol [J].
Harmer, CJ ;
Bhagwagar, Z ;
Shelley, N ;
Cowen, PJ .
PSYCHOPHARMACOLOGY, 2003, 167 (01) :112-114